Health Care

Antitrust

In light of the far reaching impact of antitrust laws on health care providers, we frequently counsel our clients concerning the antitrust implications of their current operations and proposed transactions and strategize with our clients to develop business solutions which minimize antitrust risk. We counsel clients on antitrust matters involving Sherman Act, Clayton Act and Robinson Patman Act issues as well as a broad range of antitrust questions involving franchising, pricing, refusals to deal, terminations, managed care contracting, exclusive contracts, mergers and acquisitions, joint ventures, other strategic alliances and medical staff matters. We also handle Hart-Scott-Rodino filings in connection with mergers and acquisitions.

Our health care litigators have successfully represented clients in antitrust litigation as well as agency investigations, administrative actions, and related matters involving antitrust issues. We have defended clients in investigations by the Federal Trade Commission, civil and criminal investigations by the Department of Justice, state investigations and proceedings, and litigation involving issues of monopolization, price discrimination and restraint of trade.